Mycoplasma genitalium infection: efficacy of resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5g azithromycin.
Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability.
Rédigé par : Dr Jean-Pierre Bru
Mycoplasma genitalium (MG) is highly prone to developing antimicrobial resistance. Macrolide-resistance exceeds 50% in many regions and quinolone-resistance is increasing. The emergence of high level macrolide resistance, has been attributed to the widespread use of 1g azithromycin in the treatment of sexually transmitted infections (STI) and has been related to failures and relapses.
The pr...
Ce contenu est à destination des professionnels de santé. Merci de vous identifier.
This content is intended for healthcare professionals. Thank you for identifying yourself.
This content is intended for healthcare professionals. Thank you for identifying yourself.
Déjà inscrit / Already registered ?
Créer un compte / Create an account
Créer un compte ne prend que quelques minutes et vous permettra d'accèder à l'ensemble des contenus du site.
Creating an account takes only instant and will allow you to access all the content of the website.